Increased expression of ceruloplasmin in the retina following photic injury

Molecular Vision

Volumn 9, Issue , 2003, Pages 151-158

  Chen, Lin ^a   Dentchev, Tzvete ^a   Wong, Robert ^a   Hahn, Paul ^a   Wen, Rong ^a   Bennett, Jean ^a   Dunaief, Joshua L ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Stellar Chance Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; CERULOPLASMIN; FERROUS ION; GLYCOSYLPHOSPHATIDYLINOSITOL; ISOPROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; PRIMER RNA; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPSY; CELL LABELING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGHT DAMAGE; LIGHT INTENSITY; MALE; MOUSE; MOUSE STRAIN; MUELLER CELL; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHOTOOXIDATION; PHOTORECEPTOR; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RAT; RETINA DEGENERATION; RETINA INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VITREOUS BODY; WESTERN BLOTTING; WHITE LIGHT; AGED; ANIMAL; BAGG ALBINO MOUSE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; LIGHT; METABOLISM; PATHOLOGY; RADIATION EXPOSURE; RADIATION INJURY; RETINA;

AGED; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CERULOPLASMIN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IN SITU NICK-END LABELING; LIGHT; MALE; MICE; MICE, INBRED BALB C; OXIDATIVE STRESS; RADIATION INJURIES, EXPERIMENTAL; RETINA; RETINAL DEGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; VITREOUS BODY;

EID: 0038750831     PISSN: 10900535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS report no. 8. Arch Ophthalmol 2001; 119:1417-36.
2. Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995; 36:182-91.
3. Jacobson SG, McInnes RR. Blinded by the light. Nat Genet 2002; 32:215-6.
4. Mellerio J. Light effects on the retina. In: Albert DM, Jakobiec FA, editors. Principles and practice of ophthalmology: Basic Sciences. Philadelphia: WB Saunders; 1994. p. 1326-45.
5. Rozanowska M, Jarvis-Evans J, Korytowski W, Boulton ME, Burke JM, Sarna T. Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species. J Biol Chem 1995; 270:18825-30.
6. Wassell J, Davies S, Bardsley W, Boulton M. The photoreactivity of the retinal age pigment lipofuscin. J Biol Chem 1999; 274:23828-32.
7. Sparrow JR, Zhou J, Ben-Shabat S, Vollmer H, Itagaki Y, Nakanishi K. Involvement of oxidative mechanisms in blue-light-induced damage to A2E-laden RPE. Invest Ophthalmol Vis Sci 2002; 43:1222-7.
8. Noell WK, Walker VS, Kang BS, Berman S. Retinal damage by light in rats. Invest Ophthalmol 1966; 5:450-73.
9. Hafezi F, Grimm C, Wenzel A, Abegg M, Yaniv M, Reme CE. Retinal photoreceptors are apoptosis-competent in the absence of JunD/AP-1. Cell Death Differ 1999; 6:934-6.
10. Portera-Cailliau C, Sung CH, Nathans J, Adler R. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci U S A 1994; 91:974-8.
11. Cook B, Lewis GP, Fisher SK, Adler R. Apoptotic photoreceptor degeneration in experimental retinal detachment. Invest Ophthalmol Vis Sci 1995; 36:990-6.
12. Tanito M, Masutani H, Nakamura H, Ohira A, Yodoi J. Cytoprotective effect of thioredoxin against retinal photic injury in mice. Invest Ophthalmol Vis Sci 2002; 43:1162-7.
13. Li ZY, Tso MO, Wang HM, Organisciak DT. Amelioration of photic injury in rat retina by ascorbic acid: a histopathologic study. Invest Ophthalmol Vis Sci 1985; 26:1589-98.
14. Noell WK, Organisciak DT, Ando H, Braniecki MA, Durlin C. Ascorbate and dietary protective mechanisms in retinal light damage of rats: electrophysiological, histological and DNA measurements. Prog Clin Biol Res 1987; 247:469-83.
15. Frank RN, Amin RH, Puklin JE. Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neovascular age-related macular degeneration. Am J Ophthalmol 1999; 127:694-709.
16. Osaki S, Johnson DA, Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem 1966; 241:2746-51.
17. Patel BN, Dunn RJ, Jeong SY, Zhu Q, Julien JP, David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci 2002; 22:6578-86.
18. Klomp LW, Gitlin JD. Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. Hum Mol Genet 1996; 5:1989-96.
19. Levin LA, Geszvain KM. Expression of ceruloplasmin in the retina: induction after optic nerve crush. Invest Ophthalmol Vis Sci 1998; 39:157-63.
20. Dunaief JL, Dentchev T, Ying GS, Milam AH. The role of apoptosis in age-related macular degeneration. Arch Ophthalmol 2002; 120:1435-42.
21. Patel BN, Dunn RJ, David S. Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J Biol Chem 2000; 275:4305-10.
22. Hafezi F, Abegg M, Grimm C, Wenzel A, Munz K, Sturmer J, Farber DB, Reme CE. Retinal degeneration in the rd mouse in the absence of c-fos. Invest Ophthalmol Vis Sci 1998; 39:2239-44.
23. Hanauer A, Mandel JL. The glyceraldehyde 3 phosphate dehydrogenase gene family: structure of a human cDNA and of an X chromosome linked pseudogene; amazing complexity of the gene family in mouse. EMBO J 1984; 3:2627-33.
24. Overbergh L, Valckx D, Waer M, Mathieu C. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 1999; 11:305-12.
25. Klomp LW, Farhangrazi ZS, Dugan LL, Gitlin JD. Ceruloplasmin gene expression in the murine central nervous system. J Clin Invest 1996; 98:207-15.
26. Shanmugaratnam J, Berg E, Kimerer L, Johnson RJ, Amaratunga A, Schreiber BM, Fine RE. Retinal Muller glia secrete apolipoproteins E and J which are efficiently assembled into lipoprotein particles. Brain Res Mol Brain Res 1997; 50:113-20.
27. Yu TC, Okamura R. Comparative study of native proteins in aqueous humor and serum-detection of characteristic aqueous humor proteins. Jpn J Ophthalmol 1987; 31:235-48.
28. Abdellatif M. Leading the way using microarray: a more comprehensive approach for discovery of gene expression patterns. Circ Res 2000; 86:919-20.
29. Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, Andre B, Bangham R, Benito R, Boeke JD, Bussey H, Chu AM, Connelly C, Davis K, Dietrich F, Dow SW, El Bakkoury M, Foury F, Friend SH, Gentalen E, Giaever G, Hegemann JH, Jones T, Laub M, Liao H, Davis RW, et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 1999; 285:901-6.
30. Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr 2002; 22:439-58.
31. Yefimova MG, Jeanny JC, Guillonneau X, Keller N, Nguyen-Legros J, Sergeant C, Guillou F, Courtois Y. Iron, ferritin, transferrin, and transferrin receptor in the adult rat retina. Invest Ophthalmol Vis Sci 2000; 41:2343-51.
32. Davis AA, Hunt RC. Transferrin is made and bound by photoreceptor cells. J Cell Physiol 1993; 156:280-5.
33. Hawkins KN. Contribution of plasma proteins to the vitreous of the rat. Curr Eye Res 1986; 5:655-63.
34. Harris ZL, Durley AP, Man TK, Gitlin JD. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci U S A 1999; 96:10812-7.
35. Li ZL, Lam S, Tso MO. Desferrioxamine ameliorates retinal photic injury in albino rats. Curr Eye Res 1991; 10:133-44.
36. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 1987; 37:761-7.
37. Morita H, Ikeda S, Yamamoto K, Morita S, Yoshida K, Nomoto S, Kato M, Yanagisawa N. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 1995; 37:646-56.
38. Yoshida K, Furihata K, Takeda S, Nakamura A, Yamamoto K, Morita H, Hiyamuta S, Ikeda S, Shimizu N, Yanagisawa N. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 1995; 9:267-72.
39. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, Gitlin JD. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A 1995; 92:2539-43.
40. Gitlin JD. Aceruloplasminemia. Pediatr Res 1998; 44:271-6.
41. Yamaguchi K, Takahashi S, Kawanami T, Kato T, Sasaki H. Retinal degeneration in hereditary ceruloplasmin deficiency. Ophthalmologica 1998; 212:11-4.
42. Frazer DM, Vulpe CD, McKie AT, Wilkins SJ, Trinder D, Cleghorn GJ, Anderson GJ. Cloning and gastrointestinal expression of rat hephaestin: relationship to other iron transport proteins. Am J Physiol Gastrointest Liver Physiol 2001; 281:G931-9.
43. Vulpe CD, Kuo YM, Murphy TL, Cowley L, Askwith C, Libina N, Gitschier J, Anderson GJ. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 1999; 21:195-9.